US Insulin Market Share 2022: Industry Analysis, Price Trends, Size, Growth And Forecast Till 2027 - PowerPoint PPT Presentation

About This Presentation
Title:

US Insulin Market Share 2022: Industry Analysis, Price Trends, Size, Growth And Forecast Till 2027

Description:

The rising prevalence of chronic diseases, including obesity and diabetes, is among the key factors driving the US insulin market. In addition to this, the escalating demand for insulin therapeutics is further propelling the market growth. Moreover, the growing requirement for biosimilar drugs, owing to their high efficiency and cost-effectiveness, is acting as another significant growth-inducing factor. – PowerPoint PPT presentation

Number of Views:1
Date added: 25 April 2022
Updated: 26 April 2022
Slides: 13
Provided by: peterperker
Category: Other

less

Transcript and Presenter's Notes

Title: US Insulin Market Share 2022: Industry Analysis, Price Trends, Size, Growth And Forecast Till 2027


1
Copyright 2015 International Market Analysis
Research Consulting (IMARC). All Rights Reserved
2
About Syndicated Analytics
Report Description
Syndicated Analytics, a subsidiary of IMARC
Group, offers consulting services and provides
comprehensive market intelligence in the form of
research reports, production cost reports and
feasibility studies. Our team, consisting of
experienced researchers and analysts from diverse
industries, is deeply committed to the quality of
the information and insights delivered to the
clients, which range from small and medium
enterprises to Fortune 1000 companies. These
firms are able to achieve this by studying the
qualitative and quantitative aspects of the
market as well as staying up-to-date with the
current and the evolving trends of the
industry. Our set of syndicated as well as
customized research reports and studies help
clients in conducting an early-stage analysis to
validate the availability of necessities such as
raw materials, plant and machinery, and packaging
requirements. These reports also assist
stakeholders in understanding the market trends
prevalent in the industry and gaining a better
view of their competitive landscape, overcoming
various industry-related challenges and
formulating revenue-generating business
strategies for entering the industry. Our
Intelligence Overage Our research reports
provide deep insights on market intelligence at
the global as well as the regional level,
covering the ASEAN, BRICS, and GCC countries. Our
research capabilities span across numerous
industries which include, but are not limited to,
chemicals, energy, mining, advanced materials,
pharmaceuticals, food and beverage, and
biotechnology.results.
3
Report Description and Highlights
Report Description
US Insulin Market Share 2022 Industry Analysis,
Price Trends, Size, Growth And Forecast Till
2027 US Insulin Market Industry Analysis,
Share, Market Size, Trends, Application Analysis,
Growth and Forecast, 2022-2027 provides a deep
and thorough evaluation of the US insulin market
based on its segments including type, end use and
region. The report tracks the latest industry
trends and analyses their overall impact on the
market. It also evaluates the market dynamics,
which cover the key demand and price indicators,
and studies the market on the basis of the SWOT
and Porters Five Forces models. Report
Metrics Historical Year 2016-2021Base Year
2021Forecast Year 2022-2027 Insulin represents
a peptide hormone that is produced by the beta
cells of the pancreatic islets. It is the primary
anabolic hormone of the body. Insulin assists in
regulating the metabolism of carbohydrates, fats,
and proteins by promoting the absorption of
glucose from the blood into the fat, skeletal
muscle cells, and liver. High concentrations of
this hormone in the blood tend to strongly
inhibit glucose production and secretion by the
liver. Insulin is also utilized as a solution or
suspension and is usually injected
subcutaneously. Insulin aids in inhibiting
hepatic glucose production, lipolysis, and
proteolysis, as well as improving protein
synthesis in the body. It is widely available in
retail pharmacies, online platforms, medical
stores, etc., across the US.
4
Report Description and Highlights
Report Description
US Insulin Industry Trends and Drivers The
rising prevalence of chronic diseases, including
obesity and diabetes, is among the key factors
driving the US insulin market. In addition to
this, the escalating demand for insulin
therapeutics is further propelling the market
growth. Moreover, the growing requirement for
biosimilar drugs, owing to their high efficiency
and cost-effectiveness, is acting as another
significant growth-inducing factor. Besides
this, continuous technological advancements,
including the development of pen devices and
safety pen needles to administer human insulin in
the body, are positively influencing the US
insulin market. Apart from this, the expanding
geriatric population, who are more prone to
chronic ailments, is also catalyzing the market
growth. Furthermore, the elevating health
consciousness among the masses and extensive
research and development (RD) activities in the
biotechnology sector are anticipated to stimulate
the US insulin market over the forecasted
period. Download free sample report to get
detailed insight about market https//www.syndica
tedanalytics.com/request?typereportid762flagB
5
Report Description and Highlights
Report Description
  • US Insulin Market Segmentation
  • The market is segmented in on the basis of type,
    end use and region.
  • Type
  • End use
  • Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
  • Competitive Landscape
  • The report also provides insights on the
    competitive landscape of the US insulin industry
    with the leading players profiled in the report.
  • Browse complete report with tables of contents
    and list of figures tables 

6
Table of Contents
Report Description
1 Introduction     1.1 Research Objectives    
1.2 Stakeholders    1.3 Scope of the Report   
1.4 Assumptions and Limitations2. Research
Methodology     2.1. Data Collection     
 2.1.1 Primary Sources       2.1.2 Secondary
Sources    2.2 Market Size Estimation       
2.2.1 Bottom-Up Approach        2.2.2 Top-Down
Approach    2.3 Data Validation3. Executive
Summary4. United States Insulin Market     4.1
Industry Overview     4.2 Key Industry
Developments     4.3 Market Trends        4.3.1
Key Market Indicators        4.3.2 Historical
Market Trends        4.3.3 Market Forecast   
 4.4 Price Analysis
7
Table of Contents
Report Description
4.4.1 Key Price Indicators        4.4.2 Pricing
Structure        4.4.3 Historical Price Trends 
      4.4.4 Price Forecast     4.5 Market
Breakup by Drug Class     4.6 Market Breakup by
Application     4.7 Market Breakup by Insulin
Delivery Technologies 5. United States Insulin
Market Value Chain Analysis     5.1 Overview 
   5.2 Research and Development     5.3 Raw
Material Suppliers     5.4 Inbound Logistics   
 5.5 Production     5.6 Marketing      5.7
Outbound Logistics     5.8 Consumers6. United
States Insulin Market SWOT Analysis     6.1
Overview     6.2 Strengths     6.3 Weaknesses 
   6.4 Opportunities     6.5 Threats
8
Table of Contents
Report Description
7. United States Insulin Market Porters Five
Forces Analysis     7.1 Overview     7.2 Threat
of New Entrants     7.3 Threat of Substitutes 
   7.4 Bargaining Power of Buyers     7.5
Bargaining Power of Suppliers     7.6 Intensity
of Rivalry8. Competitive Landscape     8.1
Market Structure     8.2 Key Players      8.3
Key Success Factors 9. Key Player Profiles

9
List of Figures
Report Description
Figure 1 United States Insulin Market,
2016-2021Figure 2 United States Insulin Market
Forecast, 2022-2027Figure 3 United States
Insulin Market Price Trends, 2016-2021Figure 4
United States Insulin Market Forecast Price
Trends, 2022-2027Figure 5 United States
Insulin Market Breakup by Drug Class,
2021Figure 6 United States Insulin Market for
Fast-acting Insulin, 2016, 2021 2027Figure 7
United States Insulin Market for
Intermediate-Acting Insulin, 2016, 2021
2027Figure 8 United States Insulin Market for
Long-Acting Insulin, 2016, 2021 2027Figure 9
United States Insulin Market Breakup by
Application, 2021Figure 10 United States
Insulin Market for Type 1 diabetes, 2016, 2021
2027Figure 11 United States Insulin Market for
Type 2 diabetes, 2016, 2021 2027Figure 12
United States Insulin Market Breakup by Insulin
Delivery Technologies, 2021Figure 13 United
States Insulin Market for Injectable Insulin,
2016, 2021 2027Figure 14 United States
Insulin Market for Oral Insulin, 2016, 2021
2027Figure 15 United States Insulin Market for
Inhaled Insulin, 2016, 2021 2027Figure 16
United States Insulin Market for Other Emerging
Insulin Delivery Technologies, 2016, 2021
2027Figure 17 United States Insulin Market for
Insulin Pumps, 2016, 2021 2027Figure 18
United States Insulin Industry Value Chain
AnalysisFigure 19 United States Insulin
Industry SWOT AnalysisFigure 20 United States
Insulin Industry Porters Five Forces
AnalysisFigure 21 United States Insulin
Market Breakup by Key Players, 2021

10
List of Tables
Report Description
Table 1 United States Insulin Industry Market
Summary    Table 2 United States Insulin
Industry Market Overview, 2021 and 2027Table 3
United States Insulin Industry Market Structure
 Table 4 United States Insulin Market
Forecast Breakup by Drug Class, 2022-2027Table
5 United States Insulin Market Forecast
Breakup by Application, 2022-2027Table 6 United
States Insulin Market Forecast Breakup by
Insulin Delivery Technologies, 2022-2027Table 7
United States Insulin Market Key Player

11
Terms and Conditions
Report Description

2021 Syndicated Analytics All Rights Reserved
The information and content provided on the
site, such as texts, graphics, images, designs,
etc. (the Content) are the copyrighted property
of Syndicated Analytics or its respective
licensor and are protected by the Regional and
International Copyright Laws. You have a
non-transferable and non- exclusive right to
display, print or download the Content for your
individual use on a single computer. You agree
that you will not use, modify, republish or
distribute the Content in any manner for
commercial or other purposes. You further agree
to retain all copyright or other notices on the
Content. All rights not specifically granted are
reserved. Disclaimer The information and
services provided by us are based on the data
gathered from varied sources such as interviews,
paid databases, annual reports, press releases
and surveys. This data, collected in good faith,
is used on an as is and as available basis and is
subject to fluctuations. We do not make any
guarantees and warrantees regarding the
completeness, accuracy, usefulness and
reliability of the data. Our information
products and services are meant to be used as
general information only. We insist that any
business or investment decisions should not be
made based solely on the information provided by
us. We will not be accountable for any losses
suffered by you in case of any direct, indirect,
consequential or incidental damage.
12
Contact Us
Write a Comment
User Comments (0)
About PowerShow.com